Ciphergen to Participate at the BIO CEO and Investor Conference

FREMONT, Calif., Feb. 9  /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) announced today that Eric T. Fung, M.D., Ph.D., Chief Scientific Officer, is scheduled to participate in an ovarian cancer panel discussion at the BIO CEO and Investor Conference in New York on Monday, February 12, 2007 at 3:30 p.m. in the Waldorf's Louis XVI Suite Center/West Room. The therapeutic workshop entitled, "Treatments Obviously Needed for a Not-So-Obvious Disease," will address the difficulties in detecting and treating ovarian cancer and what companies are doing to improve prognosis for women diagnosed with this disease.

About Ciphergen

Ciphergen Biosystems, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Ciphergen, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Ciphergen can be found on the web at http://www.ciphergen.com/ . 

DATASOURCE: Ciphergen Biosystems, Inc.



CONTACT:  Sue Carruthers, Investor Relations of Ciphergen Biosystems,

Inc., [phone]; or media, Lori Murray of WeissComm Partners,

[phone], for Ciphergen Biosystems, Inc.



Web site:  http://www.ciphergen.com/

Copyright